emocha, UMHP partner to improve medication adherence among Type 2 diabetes patients

Wednesday, December 12, 2018 Diabetes News
Email Print This Page Comment bookmark
Font : A-A+

Baltimore companies leverage new app with proven video technology and directly observed therapy

DLC, Dec. 12, 2018 /PRNewswire/ -- University of Maryland Health Partners (UMHP) and emocha Mobile Health today announced

the launch of a new program to support patients with Type 2 diabetes. Patients who participate in the three-month program will use a smartphone application to submit daily check-in videos of themselves taking their medication. Participants will also be paired with an emocha Adherence Coach who will review their videos, assess whether they took their medication as prescribed, and encourage them throughout treatment. At the end of the program, those who achieve a minimum medication adherence rate with their Type 2 diabetic medications will receive a $100 gift card.

"We believe in fostering strong relationships with our members through supportive care management strategies and innovative technology," said Mark Puente, president and chief executive officer of UMHP. "By creating a daily connection with our members, this new program will help to improve healthcare for the most vulnerable."

Total Health Care, a federally qualified health center (FQHC) with nine locations in Baltimore City and the surrounding areas, is also partnering with UMHP and emocha for the program. The providers and clinical support team at Total Health Care will serve as a resource to their patients who are participating if they need additional support throughout the program.

The program launched by the Baltimore-based organizations is the first of its kind to leverage video technology and a public health practice known as Directly Observed Therapy, or DOT. DOT is a CDC-endorsed model of care that has been used by public health departments for decades to contain deadly infectious diseases. DOT is the only technique proven to consistently secure medication adherence rates greater than 90 percent.

The CDC has recognized emocha's success in real-world settings. Additionally, peer-reviewed studies have demonstrated that patients using emocha achieve 94 percent adherence rates on average. Multiple health departments using emocha have demonstrated similar adherence rates and significant cost savings.

"This is a cutting-edge program that combines the health insurer, provider, pharmacists, and technology to provide daily support to patients with diabetes and other chronic conditions," said Sebastian Seiguer, CEO at emocha Mobile Health. "We're excited to work with our partners at UMHP and Total Health Care who are taking a holistic and innovative approach to medication adherence."

Patients who are interested in participating in the program should visit umhp.emocha.com to learn more.

Cision View original content:http://www.prnewswire.com/news-releases/emocha-umhp-partner-to-improve-medication-adherence-among-type-2-diabetes-patients-300764388.html

SOURCE eMocha



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store